[Tang, Shengsong; Zhou, Qun] Hunan Univ Med, Sch Pharmaceut Sci, Hunan Prov Key Lab Antibody Based Drug & Intellig, Huaihua, Peoples R China.

[Zhang, Xianhui] Dongkou Peoples Hosp, Orthoped Dept, Dongkou 422300, Hunan, Peoples R China.

[Chen, Linxi] Univ South China, Hunan Prov Key Lab Tumor Microenvironm Respons Dr, Hunan Prov Cooperat Innovat Ctr Mol Target, New Drug Study,Inst Pharm & Pharmacol, 28 Changsheng Rd, Hengyang 421001, Hunan, Peoples R China.

[Xianhui Zhang] O

[Linxi Chen] H

Orthopedics Department, Dongkou People’s Hospital, Dongkou, China<&wdkj&>Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hunan Province Cooperative Innovation Center for Molecular Target, New Drug Study, Institute of Pharmacy and Pharmacology, University of South China, Hengyang, China

binding protein;immunoglobulin enhancer binding protein;mammalian target of rapamycin;microRNA;proline rich akt substrate of 40;protein 14 3 3;protein kinase Pim 1;serine;threonine;unclassified drug;AKT1S1 protein, human;microRNA;protein kinase B;signal transducing adaptor protein;angiogenesis;apoptosis;autophagy (cellular);bioinformatics;cardiovascular disease;cell growth;degenerative disease;diabetes mellitus;drug targeting;human;malignant neoplasm;metabolic disorder;oxidative stress;Pi3K/Akt signaling;protein interaction;protein phosphorylation;reperfusion injury;Review;animal;genetics;metabolism;molecularly targeted therapy;phosphorylation;physiology;signal transduction;Adaptor Proteins, Signal Transducing;Animals;Humans;MicroRNAs;Molecular Targeted Therapy;Phosphorylation;Proto-Oncogene Proteins c-akt;Signal Transduction

药学与生物科学学院